

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.14099004 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.77422662 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.61374495 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.61374495 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 7.40011432 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.28404774 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28404774 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.89855840 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.39191311 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.27838197 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.27838197 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.27838197 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.15714849 |
| 14 | bile acid biosynthetic process (GO:0006699) | 6.04938355 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.89015886 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.86391618 |
| 17 | drug metabolic process (GO:0017144) | 5.72904468 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.70086652 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.66514128 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.65324446 |
| 21 | oxidative demethylation (GO:0070989) | 5.64446391 |
| 22 | urea cycle (GO:0000050) | 5.62873745 |
| 23 | urea metabolic process (GO:0019627) | 5.62873745 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.51429140 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.50787928 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.47658174 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45759288 |
| 28 | protein carboxylation (GO:0018214) | 5.45759288 |
| 29 | regulation of plasminogen activation (GO:0010755) | 5.38420625 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.31907300 |
| 31 | cysteine metabolic process (GO:0006534) | 5.29257078 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.17645327 |
| 33 | phenylpropanoid metabolic process (GO:0009698) | 5.14566199 |
| 34 | bile acid metabolic process (GO:0008206) | 5.14247770 |
| 35 | regulation of complement activation (GO:0030449) | 5.13098806 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 5.12027703 |
| 37 | negative regulation of blood coagulation (GO:0030195) | 5.09635471 |
| 38 | negative regulation of hemostasis (GO:1900047) | 5.09635471 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 5.00921191 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94367245 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.93686977 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.91757300 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.91016887 |
| 44 | ethanol metabolic process (GO:0006067) | 4.89988196 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.81707618 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.81417810 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.81417810 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.81417810 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.67502774 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.67502774 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.66946541 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.63963792 |
| 53 | negative regulation of coagulation (GO:0050819) | 4.63248333 |
| 54 | phospholipid efflux (GO:0033700) | 4.62113657 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.59021438 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.59021438 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 4.57632566 |
| 58 | negative regulation of wound healing (GO:0061045) | 4.57441202 |
| 59 | lysine metabolic process (GO:0006553) | 4.56048117 |
| 60 | lysine catabolic process (GO:0006554) | 4.56048117 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.54428807 |
| 62 | negative regulation of protein activation cascade (GO:2000258) | 4.52938214 |
| 63 | regulation of humoral immune response (GO:0002920) | 4.52580993 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.48838403 |
| 65 | glycine metabolic process (GO:0006544) | 4.46256835 |
| 66 | positive regulation of blood coagulation (GO:0030194) | 4.44239369 |
| 67 | positive regulation of hemostasis (GO:1900048) | 4.44239369 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 4.43537265 |
| 69 | bile acid and bile salt transport (GO:0015721) | 4.41302668 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 4.39771337 |
| 71 | amine catabolic process (GO:0009310) | 4.35563937 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 4.35563937 |
| 73 | acute-phase response (GO:0006953) | 4.34795827 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.34089629 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 4.26634958 |
| 76 | cholesterol efflux (GO:0033344) | 4.24542076 |
| 77 | glutamate metabolic process (GO:0006536) | 4.24114942 |
| 78 | alkaloid metabolic process (GO:0009820) | 4.22317598 |
| 79 | cellular glucuronidation (GO:0052695) | 4.20843902 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 4.17883029 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.12970263 |
| 82 | S-adenosylmethionine metabolic process (GO:0046500) | 4.09932592 |
| 83 | positive regulation of coagulation (GO:0050820) | 4.09791178 |
| 84 | ethanol oxidation (GO:0006069) | 4.07942109 |
| 85 | fibrinolysis (GO:0042730) | 4.07365504 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06119865 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 4.05150989 |
| 88 | intestinal cholesterol absorption (GO:0030299) | 4.03939863 |
| 89 | arginine metabolic process (GO:0006525) | 4.02468759 |
| 90 | hormone catabolic process (GO:0042447) | 3.99864742 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.99218902 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 3.98968674 |
| 93 | aldehyde catabolic process (GO:0046185) | 3.97132817 |
| 94 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96148225 |
| 95 | ketone body metabolic process (GO:1902224) | 3.93464676 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.91384579 |
| 97 | complement activation, classical pathway (GO:0006958) | 3.90831368 |
| 98 | cytolysis (GO:0019835) | 3.88634853 |
| 99 | negative regulation of complement activation (GO:0045916) | 3.87077756 |
| 100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.86443518 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.86443518 |
| 102 | heme transport (GO:0015886) | 3.85826689 |
| 103 | complement activation (GO:0006956) | 3.83818743 |
| 104 | cofactor catabolic process (GO:0051187) | 3.83320318 |
| 105 | protein activation cascade (GO:0072376) | 3.80198677 |
| 106 | drug catabolic process (GO:0042737) | 3.77397213 |
| 107 | negative regulation of lipase activity (GO:0060192) | 3.77009947 |
| 108 | regulation of lipoprotein particle clearance (GO:0010984) | 3.75762111 |
| 109 | cholesterol homeostasis (GO:0042632) | 3.74272970 |
| 110 | positive regulation of lipid catabolic process (GO:0050996) | 3.74230054 |
| 111 | carboxylic acid catabolic process (GO:0046395) | 3.73602798 |
| 112 | organic acid catabolic process (GO:0016054) | 3.73602798 |
| 113 | uronic acid metabolic process (GO:0006063) | 3.73309558 |
| 114 | glucuronate metabolic process (GO:0019585) | 3.73309558 |
| 115 | phospholipid homeostasis (GO:0055091) | 3.72523607 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70481787 |
| 117 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70418848 |
| 118 | sterol homeostasis (GO:0055092) | 3.68063442 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 3.67372115 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 3.66764184 |
| 121 | plasma lipoprotein particle organization (GO:0071827) | 3.64698070 |
| 122 | NAD biosynthetic process (GO:0009435) | 3.62157812 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 3.61092216 |
| 124 | protein-lipid complex assembly (GO:0065005) | 3.57393594 |
| 125 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.57278487 |
| 126 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.55529728 |
| 127 | flavonoid metabolic process (GO:0009812) | 3.53923401 |
| 128 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.48049712 |
| 129 | steroid catabolic process (GO:0006706) | 3.47684727 |
| 130 | regulation of apoptotic cell clearance (GO:2000425) | 3.46736918 |
| 131 | opsonization (GO:0008228) | 3.43513507 |
| 132 | xenobiotic metabolic process (GO:0006805) | 3.40774768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41480113 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.24270737 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.10698070 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51153595 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32213995 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.11841371 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84647792 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04259875 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.00468765 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06226546 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0530806 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98218561 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95842629 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59502152 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58234540 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50626307 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42416911 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39449526 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29197211 |
| 20 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22657021 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20843252 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16800745 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10355606 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05543025 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01935565 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00504882 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95970429 |
| 28 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93592089 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.92021211 |
| 30 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.90956104 |
| 31 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.88723014 |
| 32 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87241197 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86499903 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84985365 |
| 35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82877580 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.82318182 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81865338 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80026428 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79614875 |
| 40 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.78680289 |
| 41 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.78263652 |
| 42 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77942427 |
| 43 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77664559 |
| 44 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77510423 |
| 45 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76951073 |
| 46 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.75707338 |
| 47 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75422558 |
| 48 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75394439 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73202302 |
| 50 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.72952306 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.71229848 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.70250917 |
| 53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70232819 |
| 54 | NFYA_21822215_ChIP-Seq_K562_Human | 0.70005695 |
| 55 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.69496617 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68936342 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68322374 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.67874114 |
| 59 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.67804943 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.66930101 |
| 61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65846068 |
| 62 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65694488 |
| 63 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65642502 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65006733 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.64874300 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.63916478 |
| 67 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63048445 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62623457 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62040214 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61976282 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61976282 |
| 72 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.61915492 |
| 73 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60799824 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60726758 |
| 75 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.59829957 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.59238569 |
| 77 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.59116530 |
| 78 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.58711900 |
| 79 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.58643238 |
| 80 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.57101033 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56858565 |
| 82 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56427810 |
| 83 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.56170192 |
| 84 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56074143 |
| 85 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.54911863 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.54163132 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54099916 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54051409 |
| 89 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53632064 |
| 90 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.53032871 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52471486 |
| 92 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52409808 |
| 93 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.52110411 |
| 94 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51835813 |
| 95 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.51722582 |
| 96 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51706500 |
| 97 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51205356 |
| 98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.51141561 |
| 99 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.51052454 |
| 100 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.50798157 |
| 101 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.50420810 |
| 102 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50310382 |
| 103 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.50280080 |
| 104 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.49786158 |
| 105 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49692050 |
| 106 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49620413 |
| 107 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.49598505 |
| 108 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45826265 |
| 109 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45431757 |
| 110 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.44358527 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.44138043 |
| 112 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.44044476 |
| 113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43657627 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43538222 |
| 115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42508190 |
| 116 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42422383 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42313539 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42119934 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41972452 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41068009 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40392086 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39847611 |
| 123 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.39676478 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39258759 |
| 125 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38883483 |
| 126 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38853446 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38434168 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38121321 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37453337 |
| 130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.36973252 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.36842785 |
| 132 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.36772368 |
| 133 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36658864 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.35880127 |
| 135 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35361815 |
| 136 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34554830 |
| 137 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34246990 |
| 138 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33806013 |
| 139 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33357711 |
| 140 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33331409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.40436062 |
| 2 | MP0005360_urolithiasis | 7.53415799 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.48942405 |
| 4 | MP0005365_abnormal_bile_salt | 6.19936891 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.05935089 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26540240 |
| 7 | MP0003252_abnormal_bile_duct | 3.94102441 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.61423055 |
| 9 | MP0009840_abnormal_foam_cell | 3.33576916 |
| 10 | MP0005083_abnormal_biliary_tract | 3.06762191 |
| 11 | MP0003195_calcinosis | 2.80104392 |
| 12 | MP0005332_abnormal_amino_acid | 2.73448972 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.61255556 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.37615535 |
| 15 | MP0000609_abnormal_liver_physiology | 2.16789395 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.11127730 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.10362015 |
| 18 | MP0003868_abnormal_feces_composition | 1.95790569 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.93456770 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83255090 |
| 21 | MP0001764_abnormal_homeostasis | 1.65383139 |
| 22 | MP0009697_abnormal_copulation | 1.59280577 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55893557 |
| 24 | MP0005451_abnormal_body_composition | 1.46010085 |
| 25 | MP0003011_delayed_dark_adaptation | 1.40632011 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.27245435 |
| 27 | MP0003186_abnormal_redox_activity | 1.24364934 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.20545339 |
| 29 | MP0005647_abnormal_sex_gland | 1.19388680 |
| 30 | MP0000598_abnormal_liver_morphology | 1.17274199 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.17107469 |
| 32 | MP0000604_amyloidosis | 1.07950404 |
| 33 | MP0009764_decreased_sensitivity_to | 1.05123176 |
| 34 | MP0009763_increased_sensitivity_to | 1.01368707 |
| 35 | MP0001915_intracranial_hemorrhage | 1.00921591 |
| 36 | MP0002254_reproductive_system_inflammat | 1.00302142 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.00181430 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.91221745 |
| 39 | * MP0008469_abnormal_protein_level | 0.86254562 |
| 40 | * MP0009642_abnormal_blood_homeostasis | 0.85786057 |
| 41 | MP0005408_hypopigmentation | 0.83494126 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 0.81239571 |
| 43 | MP0005376_homeostasis/metabolism_phenot | 0.79677111 |
| 44 | MP0005187_abnormal_penis_morphology | 0.78512933 |
| 45 | MP0002876_abnormal_thyroid_physiology | 0.78428759 |
| 46 | MP0005670_abnormal_white_adipose | 0.77787907 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.77165311 |
| 48 | MP0009765_abnormal_xenobiotic_induced | 0.76754213 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 0.74318083 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 0.72385748 |
| 51 | MP0002971_abnormal_brown_adipose | 0.70158313 |
| 52 | MP0004130_abnormal_muscle_cell | 0.68282459 |
| 53 | MP0005334_abnormal_fat_pad | 0.68180457 |
| 54 | MP0005535_abnormal_body_temperature | 0.67436857 |
| 55 | MP0003690_abnormal_glial_cell | 0.66830409 |
| 56 | MP0009053_abnormal_anal_canal | 0.65772596 |
| 57 | MP0001661_extended_life_span | 0.65390842 |
| 58 | MP0005266_abnormal_metabolism | 0.64725635 |
| 59 | MP0005058_abnormal_lysosome_morphology | 0.63258718 |
| 60 | MP0000639_abnormal_adrenal_gland | 0.61897359 |
| 61 | MP0003879_abnormal_hair_cell | 0.61655299 |
| 62 | MP0003329_amyloid_beta_deposits | 0.61437563 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 0.57274847 |
| 64 | MP0001756_abnormal_urination | 0.56873610 |
| 65 | MP0002282_abnormal_trachea_morphology | 0.56650525 |
| 66 | MP0005448_abnormal_energy_balance | 0.54581462 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.51759632 |
| 68 | MP0000566_synostosis | 0.51546106 |
| 69 | MP0002822_catalepsy | 0.50899917 |
| 70 | MP0005395_other_phenotype | 0.48993260 |
| 71 | MP0004381_abnormal_hair_follicle | 0.48441554 |
| 72 | MP0003718_maternal_effect | 0.47585574 |
| 73 | MP0003638_abnormal_response/metabolism_ | 0.45696933 |
| 74 | MP0008874_decreased_physiological_sensi | 0.44886446 |
| 75 | MP0002928_abnormal_bile_duct | 0.44779956 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.43294195 |
| 77 | MP0008873_increased_physiological_sensi | 0.42845798 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.42592739 |
| 79 | MP0003724_increased_susceptibility_to | 0.42072480 |
| 80 | MP0002837_dystrophic_cardiac_calcinosis | 0.41570933 |
| 81 | MP0003436_decreased_susceptibility_to | 0.41558805 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 0.41158606 |
| 83 | MP0005023_abnormal_wound_healing | 0.40913061 |
| 84 | MP0003075_altered_response_to | 0.40563572 |
| 85 | MP0005166_decreased_susceptibility_to | 0.40169238 |
| 86 | MP0003953_abnormal_hormone_level | 0.40094398 |
| 87 | MP0005248_abnormal_Harderian_gland | 0.39637457 |
| 88 | MP0000579_abnormal_nail_morphology | 0.37900529 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.36566081 |
| 90 | MP0009785_altered_susceptibility_to | 0.36311676 |
| 91 | MP0008872_abnormal_physiological_respon | 0.36077876 |
| 92 | MP0009672_abnormal_birth_weight | 0.35904073 |
| 93 | MP0002796_impaired_skin_barrier | 0.35257606 |
| 94 | MP0009384_cardiac_valve_regurgitation | 0.32982995 |
| 95 | MP0002089_abnormal_postnatal_growth/wei | 0.32653913 |
| 96 | MP0004883_abnormal_blood_vessel | 0.32640563 |
| 97 | MP0009115_abnormal_fat_cell | 0.32572259 |
| 98 | MP0000249_abnormal_blood_vessel | 0.31946171 |
| 99 | MP0006082_CNS_inflammation | 0.31707424 |
| 100 | MP0002970_abnormal_white_adipose | 0.30377392 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.30297218 |
| 102 | MP0001243_abnormal_dermal_layer | 0.29677627 |
| 103 | MP0001853_heart_inflammation | 0.29452316 |
| 104 | MP0002168_other_aberrant_phenotype | 0.29324247 |
| 105 | MP0001881_abnormal_mammary_gland | 0.27042482 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.26996887 |
| 107 | MP0003959_abnormal_lean_body | 0.26849813 |
| 108 | MP0002132_abnormal_respiratory_system | 0.26024181 |
| 109 | MP0005164_abnormal_response_to | 0.25439303 |
| 110 | MP0004272_abnormal_basement_membrane | 0.25085964 |
| 111 | MP0005197_abnormal_uvea_morphology | 0.23231574 |
| 112 | MP0003122_maternal_imprinting | 0.23125960 |
| 113 | MP0002060_abnormal_skin_morphology | 0.23011290 |
| 114 | MP0000427_abnormal_hair_cycle | 0.22277312 |
| 115 | MP0003632_abnormal_nervous_system | 0.20963567 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.20890066 |
| 117 | MP0002090_abnormal_vision | 0.20362841 |
| 118 | MP0000920_abnormal_myelination | 0.19227393 |
| 119 | MP0001944_abnormal_pancreas_morphology | 0.18619410 |
| 120 | MP0002128_abnormal_blood_circulation | 0.17868441 |
| 121 | MP0003172_abnormal_lysosome_physiology | 0.17853231 |
| 122 | MP0001851_eye_inflammation | 0.16353754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.49368637 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.41639840 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.40057286 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.67284706 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.65085343 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.39698503 |
| 7 | Xanthomatosis (HP:0000991) | 6.26779915 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.64466917 |
| 9 | Complement deficiency (HP:0004431) | 5.62167191 |
| 10 | Joint hemorrhage (HP:0005261) | 4.85493778 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.82204326 |
| 12 | Hyperammonemia (HP:0001987) | 4.58784374 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.49151207 |
| 14 | Hyperglycinemia (HP:0002154) | 4.47611776 |
| 15 | Epidermoid cyst (HP:0200040) | 4.44741518 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39210575 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.26635509 |
| 18 | Ketosis (HP:0001946) | 4.26182999 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 4.24052912 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21820471 |
| 21 | Fat malabsorption (HP:0002630) | 4.15954566 |
| 22 | Abnormality of complement system (HP:0005339) | 4.10584828 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06841091 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.99938692 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.89425108 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.89425108 |
| 27 | Hyperglycinuria (HP:0003108) | 3.89252449 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.88053915 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.84586317 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.81313107 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.72275731 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.55028683 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38836854 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34984398 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.32007248 |
| 36 | Osteomalacia (HP:0002749) | 3.30192075 |
| 37 | Steatorrhea (HP:0002570) | 3.18130227 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.10965458 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 3.08130467 |
| 40 | Spontaneous abortion (HP:0005268) | 3.07376448 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.05835456 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03687072 |
| 43 | Ketoacidosis (HP:0001993) | 2.99300832 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.98373080 |
| 45 | Myocardial infarction (HP:0001658) | 2.96753401 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.85132358 |
| 47 | Metabolic acidosis (HP:0001942) | 2.74632437 |
| 48 | Skin nodule (HP:0200036) | 2.73308100 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.68598874 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.64874055 |
| 51 | Purpura (HP:0000979) | 2.59767784 |
| 52 | Lethargy (HP:0001254) | 2.58744831 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57691479 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.57691479 |
| 55 | Vascular calcification (HP:0004934) | 2.54581238 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52343259 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.48969645 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.47469426 |
| 59 | Gout (HP:0001997) | 2.45954172 |
| 60 | Spastic diplegia (HP:0001264) | 2.45089140 |
| 61 | Acanthocytosis (HP:0001927) | 2.44209600 |
| 62 | Cholelithiasis (HP:0001081) | 2.42279115 |
| 63 | Mitral stenosis (HP:0001718) | 2.41816559 |
| 64 | Glomerulonephritis (HP:0000099) | 2.41312303 |
| 65 | Fair hair (HP:0002286) | 2.39716096 |
| 66 | Arthropathy (HP:0003040) | 2.38998968 |
| 67 | Cerebral edema (HP:0002181) | 2.38120276 |
| 68 | Cholecystitis (HP:0001082) | 2.37145214 |
| 69 | Abnormal gallbladder physiology (HP:0012438) | 2.37145214 |
| 70 | Neonatal onset (HP:0003623) | 2.37095394 |
| 71 | Irritability (HP:0000737) | 2.32931921 |
| 72 | Pulmonary embolism (HP:0002204) | 2.32664613 |
| 73 | Amyloidosis (HP:0011034) | 2.32055457 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.25484382 |
| 75 | Malnutrition (HP:0004395) | 2.22569277 |
| 76 | Hyperphosphaturia (HP:0003109) | 2.22261212 |
| 77 | Gingival bleeding (HP:0000225) | 2.22139243 |
| 78 | Sensorimotor neuropathy (HP:0007141) | 2.19542673 |
| 79 | Esophageal varix (HP:0002040) | 2.17318606 |
| 80 | Menorrhagia (HP:0000132) | 2.15958059 |
| 81 | Pancreatitis (HP:0001733) | 2.15747152 |
| 82 | Late onset (HP:0003584) | 2.12976919 |
| 83 | Brushfield spots (HP:0001088) | 2.12846322 |
| 84 | Enlarged kidneys (HP:0000105) | 2.11504976 |
| 85 | Thrombophlebitis (HP:0004418) | 2.10244127 |
| 86 | Abnormality of the Achilles tendon (HP:0005109) | 2.09600650 |
| 87 | Vomiting (HP:0002013) | 2.05178981 |
| 88 | Opisthotonus (HP:0002179) | 2.04491931 |
| 89 | Neonatal hypoglycemia (HP:0001998) | 2.03521154 |
| 90 | Abnormality of urine glucose concentration (HP:0011016) | 2.03508953 |
| 91 | Glycosuria (HP:0003076) | 2.03508953 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02403603 |
| 93 | Abnormality of the gallbladder (HP:0005264) | 2.02180174 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.01806285 |
| 95 | Generalized aminoaciduria (HP:0002909) | 2.00280646 |
| 96 | Elevated alkaline phosphatase (HP:0003155) | 1.99707225 |
| 97 | Poikilocytosis (HP:0004447) | 1.96659311 |
| 98 | Rickets (HP:0002748) | 1.93705821 |
| 99 | Bifid scrotum (HP:0000048) | 1.92393056 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 1.90257526 |
| 101 | Bile duct proliferation (HP:0001408) | 1.88969010 |
| 102 | Abnormal biliary tract physiology (HP:0012439) | 1.88969010 |
| 103 | Hypophosphatemic rickets (HP:0004912) | 1.86871098 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86527975 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 1.86444332 |
| 106 | Renal cortical cysts (HP:0000803) | 1.84352410 |
| 107 | Elevated hepatic transaminases (HP:0002910) | 1.82558855 |
| 108 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.82146621 |
| 109 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81426274 |
| 110 | Increased serum ferritin (HP:0003281) | 1.80878624 |
| 111 | Status epilepticus (HP:0002133) | 1.80760302 |
| 112 | Abnormal urine phosphate concentration (HP:0012599) | 1.79728536 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 1.76555349 |
| 114 | Hydroxyprolinuria (HP:0003080) | 1.76555349 |
| 115 | Hyperglycemia (HP:0003074) | 1.75462380 |
| 116 | Gangrene (HP:0100758) | 1.73038729 |
| 117 | Increased mean platelet volume (HP:0011877) | 1.71653765 |
| 118 | Abnormality of vitamin metabolism (HP:0100508) | 1.71334481 |
| 119 | Nephritis (HP:0000123) | 1.71317226 |
| 120 | Alkalosis (HP:0001948) | 1.71033293 |
| 121 | Epistaxis (HP:0000421) | 1.70778941 |
| 122 | Joint swelling (HP:0001386) | 1.62039537 |
| 123 | Generalized hypopigmentation of hair (HP:0011358) | 1.59635666 |
| 124 | Hypophosphatemia (HP:0002148) | 1.56172822 |
| 125 | Reticulocytosis (HP:0001923) | 1.55475320 |
| 126 | Abnormal platelet volume (HP:0011876) | 1.53800387 |
| 127 | Impaired platelet aggregation (HP:0003540) | 1.53353827 |
| 128 | Abnormal platelet function (HP:0011869) | 1.53353827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.25364179 |
| 2 | FGFR4 | 4.74245476 |
| 3 | ERN1 | 4.72301197 |
| 4 | SIK1 | 4.53888528 |
| 5 | TAOK3 | 3.15031207 |
| 6 | ERBB4 | 3.06666624 |
| 7 | PIK3CA | 2.90062938 |
| 8 | INSRR | 2.86064734 |
| 9 | MAP2K4 | 2.38085231 |
| 10 | PKN2 | 2.07683833 |
| 11 | MST1R | 2.03556781 |
| 12 | MAPK11 | 1.94295314 |
| 13 | FLT3 | 1.81544097 |
| 14 | TRIB3 | 1.79651316 |
| 15 | PIK3CG | 1.74987436 |
| 16 | TYK2 | 1.68831680 |
| 17 | BLK | 1.66968142 |
| 18 | LATS1 | 1.65076387 |
| 19 | PRPF4B | 1.59207880 |
| 20 | CDK12 | 1.52513881 |
| 21 | DAPK2 | 1.50424664 |
| 22 | ABL2 | 1.49441770 |
| 23 | PTK6 | 1.44680345 |
| 24 | NEK9 | 1.38673948 |
| 25 | MAP3K2 | 1.34945485 |
| 26 | FGFR2 | 1.33181297 |
| 27 | KDR | 1.30422704 |
| 28 | EIF2AK1 | 1.30284344 |
| 29 | FRK | 1.23397499 |
| 30 | JAK2 | 1.22880992 |
| 31 | NTRK3 | 1.22209016 |
| 32 | MAP3K7 | 1.18373925 |
| 33 | PINK1 | 1.12272459 |
| 34 | GRK6 | 1.09522127 |
| 35 | PRKAA2 | 1.09344098 |
| 36 | MAP2K3 | 1.06745558 |
| 37 | ERBB2 | 1.04695747 |
| 38 | SCYL2 | 1.04528897 |
| 39 | TBK1 | 1.03983970 |
| 40 | JAK1 | 1.00434826 |
| 41 | MAPK4 | 0.98767002 |
| 42 | MAP3K10 | 0.96245194 |
| 43 | NLK | 0.95991187 |
| 44 | PRKG1 | 0.94484974 |
| 45 | PRKCZ | 0.92844634 |
| 46 | MAP3K14 | 0.91240495 |
| 47 | STK38L | 0.89907944 |
| 48 | CSNK1D | 0.88880727 |
| 49 | MAPK15 | 0.88434749 |
| 50 | EPHB1 | 0.86217787 |
| 51 | MAPK12 | 0.82626863 |
| 52 | MET | 0.82138124 |
| 53 | CDK6 | 0.81489547 |
| 54 | MAP3K3 | 0.81169327 |
| 55 | MAP3K11 | 0.80028706 |
| 56 | TIE1 | 0.79733477 |
| 57 | SGK1 | 0.78771532 |
| 58 | EPHA3 | 0.78641169 |
| 59 | PDK2 | 0.77452237 |
| 60 | PRKACG | 0.75507347 |
| 61 | CAMK2G | 0.73940118 |
| 62 | PRKACA | 0.71587960 |
| 63 | TNK2 | 0.71163865 |
| 64 | DYRK1B | 0.69896304 |
| 65 | GSK3A | 0.66998734 |
| 66 | MAP2K6 | 0.66946026 |
| 67 | CSK | 0.66043002 |
| 68 | PRKCB | 0.65494889 |
| 69 | PRKAA1 | 0.65378719 |
| 70 | IRAK3 | 0.65318300 |
| 71 | RPS6KA3 | 0.63862152 |
| 72 | CAMK1D | 0.63810805 |
| 73 | FGFR1 | 0.63184022 |
| 74 | CSNK1E | 0.60908951 |
| 75 | SGK3 | 0.60727869 |
| 76 | MAPK7 | 0.59776430 |
| 77 | WNK3 | 0.58260572 |
| 78 | PDGFRA | 0.57676522 |
| 79 | PTK2 | 0.56251858 |
| 80 | RIPK1 | 0.56183587 |
| 81 | MUSK | 0.55264315 |
| 82 | CSF1R | 0.54464519 |
| 83 | FGFR3 | 0.54006614 |
| 84 | TGFBR2 | 0.53527675 |
| 85 | RPS6KB1 | 0.53502384 |
| 86 | IKBKE | 0.52473448 |
| 87 | CSNK2A2 | 0.52429101 |
| 88 | CSNK2A1 | 0.51218876 |
| 89 | PDPK1 | 0.50588495 |
| 90 | TAOK2 | 0.50022776 |
| 91 | WNK4 | 0.49916545 |
| 92 | PRKCQ | 0.49551187 |
| 93 | CSNK1G1 | 0.49124926 |
| 94 | FER | 0.48717120 |
| 95 | PRKACB | 0.48567784 |
| 96 | MAP3K12 | 0.47988681 |
| 97 | PKN1 | 0.46785236 |
| 98 | GRK1 | 0.46283983 |
| 99 | EPHA4 | 0.45998130 |
| 100 | SRC | 0.45771026 |
| 101 | MAP3K5 | 0.44076311 |
| 102 | SGK2 | 0.43949957 |
| 103 | PRKCG | 0.43410870 |
| 104 | CDK4 | 0.43404179 |
| 105 | KSR2 | 0.43198472 |
| 106 | ZAP70 | 0.42682234 |
| 107 | ICK | 0.42330696 |
| 108 | IGF1R | 0.41881235 |
| 109 | STK38 | 0.39892915 |
| 110 | MAP2K1 | 0.39433111 |
| 111 | CAMKK2 | 0.39413286 |
| 112 | RET | 0.39257386 |
| 113 | MAP3K13 | 0.38633616 |
| 114 | MAP3K6 | 0.37906821 |
| 115 | CDK7 | 0.37698342 |
| 116 | MYLK | 0.37635024 |
| 117 | MTOR | 0.35668459 |
| 118 | LATS2 | 0.35531945 |
| 119 | CAMKK1 | 0.35073171 |
| 120 | MAPK3 | 0.34915962 |
| 121 | CSNK1A1 | 0.34797640 |
| 122 | EGFR | 0.34343262 |
| 123 | CAMK4 | 0.33969989 |
| 124 | NEK1 | 0.32252023 |
| 125 | MAP3K1 | 0.32088246 |
| 126 | PBK | 0.29493713 |
| 127 | PDK1 | 0.29300808 |
| 128 | SGK494 | 0.28803451 |
| 129 | SGK223 | 0.28803451 |
| 130 | CSNK1G2 | 0.28192018 |
| 131 | CSNK1G3 | 0.27022890 |
| 132 | IRAK1 | 0.25399170 |
| 133 | PRKCA | 0.25261649 |
| 134 | IRAK2 | 0.24044565 |
| 135 | CAMK1G | 0.21143831 |
| 136 | MAP2K2 | 0.20807210 |
| 137 | ABL1 | 0.20803785 |
| 138 | PAK3 | 0.20028746 |
| 139 | BMX | 0.19301479 |
| 140 | AKT3 | 0.19130960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.63560458 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.50961470 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39597781 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30363642 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.03807121 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83313490 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70468203 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70393408 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67081831 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54940296 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50010195 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39443413 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21019603 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17165908 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.10340302 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09774429 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92497292 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91746838 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90575750 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89094653 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89005428 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88400121 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82306535 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77820971 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75280094 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72446570 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70834553 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69759207 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68393035 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66823087 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64906510 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57020060 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56867219 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51959533 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.50179309 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49836274 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46697657 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37135085 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36287902 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34022374 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31203018 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25851144 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23359560 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.18783992 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17998446 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17369323 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17356706 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11471774 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05596429 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03625358 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01685904 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98598910 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98245787 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96279567 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95498332 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87569867 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84793093 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81999625 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80659834 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76683058 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69276503 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66430550 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63094559 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56437674 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52394653 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45987896 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44854939 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.44283893 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43480235 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.32923804 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26573344 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25768864 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.23208264 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22975202 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22844546 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21808367 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19145300 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16550826 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10517589 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.09974817 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01936046 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2373835 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2358379 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2338052 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2259515 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2225223 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1966862 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1914867 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1914733 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1810910 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1796369 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1761481 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1602380 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1526981 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1516347 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1479024 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | -0.1427905 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1393069 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1365693 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1286060 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1272093 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1214887 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1009506 |
| 104 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0868408 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0730698 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0713669 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0706019 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0385835 |

